These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38352977)

  • 41. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats.
    Marchand JE; Cepeda MS; Carr DB; Wurm WH; Kream RM
    Pain; 1999 Feb; 79(2-3):187-200. PubMed ID: 10068164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia.
    Kaijser L; Pernow J; Berglund B; Lundberg JM
    Clin Physiol; 1990 Mar; 10(2):179-88. PubMed ID: 2318028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.
    Poncet MF; Damase-Michel C; Tavernier G; Tran MA; Berlan M; Montastruc JL; Montastruc P
    Br J Pharmacol; 1992 Jan; 105(1):181-3. PubMed ID: 1596679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat.
    Hellström PM; Olerup O; Tatemoto K
    Acta Physiol Scand; 1985 Aug; 124(4):613-24. PubMed ID: 2864782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Kalla M; Hao G; Tapoulal N; Tomek J; Liu K; Woodward L; ; Dall'Armellina E; Banning AP; Choudhury RP; Neubauer S; Kharbanda RK; Channon KM; Ajijola OA; Shivkumar K; Paterson DJ; Herring N
    Eur Heart J; 2020 Jun; 41(23):2168-2179. PubMed ID: 31834357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.
    Shanks J; Herring N
    Am J Physiol Regul Integr Comp Physiol; 2013 Dec; 305(12):R1411-20. PubMed ID: 24005254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
    Ahlborg G; Lundberg JM
    Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
    Ilebekk A; Björkman JA; Nordlander M
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):474-80. PubMed ID: 16160600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation.
    Lundberg JM; Anggård A; Theodorsson-Norheim E; Pernow J
    Neurosci Lett; 1984 Nov; 52(1-2):175-80. PubMed ID: 6098874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
    Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
    Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roles of neuropeptide Y and noradrenaline in sympathetic neurotransmission to the thoracic vena cava and aorta of guinea-pigs.
    Morris JL
    Regul Pept; 1991 Feb; 32(3):297-310. PubMed ID: 1678196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonidine but not propranolol decreases plasma neuropeptide Y (NPY) levels.
    Poncet MF; Damase-Michel C; Valet P; Tran MA; Montastruc JL; Montastruc P
    Fundam Clin Pharmacol; 1991; 5(6):473-80. PubMed ID: 1955194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
    Warner MR; Levy MN
    Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of neuropeptide Y in cardiac sympathetic nerves induces stress (Takotsubo) cardiomyopathy.
    Arai T; Kanazawa H; Kimura K; Munakata M; Yamakawa H; Shinmura K; Yuasa S; Sano M; Fukuda K
    Front Neurosci; 2022; 16():1013712. PubMed ID: 36408384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.
    Sigala B; McKee C; Soeda J; Pazienza V; Morgan M; Lin CI; Selden C; Vander Borght S; Mazzoccoli G; Roskams T; Vinciguerra M; Oben JA
    PLoS One; 2013; 8(9):e72928. PubMed ID: 24019886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The neuropeptide galanin promotes an anti-thrombotic phenotype on endocardial endothelial cells from heart failure patients.
    Tyrrell C; Toyooka A; Khan F; Thornburg KL; Mudd JO; Hasan W
    Auton Neurosci; 2017 Sep; 206():35-42. PubMed ID: 28720509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of adenosine A2A and A3 receptors on the differential modulation of norepinephrine and neuropeptide Y release from peripheral sympathetic nerve terminals.
    Donoso MV; Aedo F; Huidobro-Toro JP
    J Neurochem; 2006 Mar; 96(6):1680-95. PubMed ID: 16539684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.
    Christmas KM; Patik JC; Khoshnevis S; Diller KR; Brothers RM
    Microvasc Res; 2018 Jan; 115():52-57. PubMed ID: 28842183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.